GYRE | tickerfilter.com

Fundamental analysis

49%

Profitability 48%

Dept financing 29%

Liquidity 75%

Performance 50%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-5.48%

1 Month

10.25%

3 Months

3.76%

6 Months

7.67%

1 Year

-25.54%

2 Year

-59.45%

Key data

Stock price

$8.28

P/E Ratio

108.03

DAY RANGE

$8.02 - $8.48

EPS

$0.08

52 WEEK RANGE

$6.11 - $13.75

52 WEEK CHANGE

-$22.62

MARKET CAP

718.496 M

YIELD

N/A

SHARES OUTSTANDING

96.333 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-12-2025

BETA

1.49

PUBLIC FLOAT

AVERAGE 10 VOLUME

$105,916

AVERAGE 30 VOLUME

$72,816

Company detail

CEO: Han Ying
Region: US
Website: www.gyretx.com
Employees: 40
IPO year: 2015

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Gyre Therapeutics is a biopharmaceutical company headquartered in San Diego, CA.

GYRE - GYRE THERAPEUTICS, INC.